Yayoi Kimoto-Matsumura
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Negative impact of immunoparesis in response to anti-SARS-CoV-2 mRNA vaccination of patients with multiple myeloma.
Journal: International journal of hematology
Published: July 03, 2023
miR-17-92 cluster-BTG2 axis regulates B-cell receptor signaling in mantle cell lymphoma.
Journal: Cancer science
Published: May 30, 2023
Impact of Treatment with Anti-CD20 Monoclonal Antibody on the Production of Neutralizing Antibody Against Anti-SARS-CoV-2 Vaccination in Mature B-Cell Neoplasms.
Journal: Infection and drug resistance
Published: November 09, 2022
The Rationale for the Dual-Targeting Therapy for RSK2 and AKT in Multiple Myeloma.
Journal: International journal of molecular sciences
Published: January 25, 2022
Gastric Myeloid Sarcoma Mimicking a Scirrhous Gastric Cancer.
Journal: Internal medicine (Tokyo, Japan)
Published: October 07, 2021
Clinical impacts of frailty, poor performance status, and advanced age in carfilzomib-containing treatment for relapsed/refractory multiple myeloma: post hoc investigation of the KOTOSG multicenter pilot prospective observational study.
Journal: International journal of hematology
Published: October 01, 2021
Combination of Bone Marrow Biopsy and Flow Cytometric Analysis: The Prognostically Relevant Central Approach for Detecting Bone Marrow Invasion in Diffuse Large B-Cell Lymphoma.
Journal: Diagnostics (Basel, Switzerland)
Published: August 31, 2021
Prognostic impact of resistance to bortezomib and/or lenalidomide in carfilzomib-based therapies for relapsed/refractory multiple myeloma: The Kyoto Clinical Hematology Study Group, multicenter, pilot, prospective, observational study in Asian patients.
Journal: Cancer reports (Hoboken, N.J.)
Published: February 21, 2021
EWSR1 overexpression is a pro-oncogenic event in multiple myeloma.
Journal: International journal of hematology
Published: July 06, 2020
Lenalidomide and pomalidomide potently interfere with induction of myeloid-derived suppressor cells in multiple myeloma.
Journal: British journal of haematology
Published: February 22, 2020
Tuberculosis Peritonitis During Treatment of Polycythemia Vera with Ruxolitinib.
Journal: Infection and drug resistance
Published: February 09, 2020
Last Updated: 09/26/2026